Journal of Commercial Biotechnology: Unmissable Management Articles
I have selected these management-themed articles from the Journal of Commercial Biotechnology, exploring the practical aspects of product innovation, R&D, patent law and marketing. The collection is divided into distinct sections: Commentary; Policy; Commercial Strategy; Valuation/Licensing; Funding; Intellectual Property; International; and Case Studies.
These articles are only fully readable for a limited period of time, so please feel free to read, download and forward them on to your colleagues while they are still available.
You can view the full collection on the Journal’s website: alternatively, the articles included in this collection are listed below:
Commentary
Building biotechnology by design: Role of biotechnology in development
Patrick Nef
Why data exclusivity is the new patent protection
Peter J Pitts
The UK Government’s strategic approach to the biotechnology industry
Lord Sainsbury
Policy
Public–private partnerships in trust-based public health social networking: Connecting organizations for regional disease surveillance (CORDS)
Louise S Greshama, Leslie A Pray, Suwit Wibulpolprasert, Beverly Trayner
Building biotechnology in Okinawa
Yali Friedman
Startup America: What it includes and opportunities for innovators
David B Orange
Commercial Strategy
Revitalizing portfolio decision-making at Merck Serono S.A.
Vincent Aurentz, Bernhard Kirschbaum and Markus Thunecke
Rethinking commercial strategy – A patient-centered commercial model
Sanjay K Rao
Building biotechnology teams: Personality does matter
Anne S York, Kim A McCarthy and Todd C Darnold
Valuation/Licensing
Practical approaches to early stage life sciences technology valuations
Stephen Mayhew
Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumb
Nigel Borshell and Adrian Dawkes
Valuation of complex license contracts
Ralph Villiger and Boris Bogdan
Finance
R&D spending and sources of funding of private US biopharmaceutical firms seeking to go public
David R Williams and Richard W Pouder
Multiyear patterns regarding the relative availability of venture capital for the US biotechnology industry
J Leslie Glick
When should you fire the founder
William Bains
Intellectual Property
Dominating global intellectual property: Overview of patentability in the USA, Europe and Japan
Thomas J Kowalski, Antonio Maschio and Samuel H Megerditchian
Kinik: Raising the stakes for importing products derived from US patented processes practised abroad
Scott B Familant
International
Bioentrepreneurship in Japan: Institutional transformation and the growth of bioventures
Michael J Lynskey
Biotechnology in Cuba: 20 years of scientific, social and economic progress
Ernesto López Mola, Ricardo Silva, Boris Acevedo, José A Buxadó, Angel Aguilera and Luis Herrera
China 10-Point Patent Checklist: Integrating patents into an overall business strategy for a Western manufacturing entity in China
Catherine Sun, Sharon R Barner and Harold C Wegner
Commercial Case Study
Beacon Sciences: Commercialisation from biothreat detection to beauty enhancement
Rob Hanes, Damon Borich
Thank you very much for categorically sharing the JCB Management Articles.